1. 0D to 1D Switching of Hybrid Polyoxometalate Assemblies at the Nanoscale by Using Molecular Control. Issue 10 (5th August 2013) Authors: Chen, Wei; Ma, Dui; Yan, Jun; Boyd, Thomas; Cronin, Leroy; Long, De‐Liang; Song, Yu‐Fei Journal: ChemPlusChem Issue: Volume 78:Issue 10(2013:Oct.) Page Start: 1226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A novel skin brightening topical technology. (12th October 2020) Authors: Draelos, Zoe Diana; Diaz, Isabel; Cohen, Aaron; Mao, Junhong; Boyd, Thomas Journal: Journal of cosmetic dermatology Issue: Volume 19:Number 12(2020) Page Start: 3280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial. Issue 9980 (9th May 2015) Authors: Hillmen, Peter; Robak, Tadeusz; Janssens, Ann; Babu, K Govind; Kloczko, Janusz; Grosicki, Sebastian; Doubek, Michael; Panagiotidis, Panagiotis; Kimby, Eva; Schuh, Anna; Pettitt, Andrew R; Boyd, Thomas; Montillo, Marco; Gupta, Ira V; Wright, Oliver; Dixon, Iestyn; Carey, Jodi L; Chang, Chai-Ni; Li... Journal: Lancet Issue: Volume 385:Issue 9980(2015) Page Start: 1873 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Demystifying the mechanism of action of professional facial peeling: In‐vivo visualization and quantification of changes in inflammation, melanin and collagen using Vivascope® and ConfoScan®. Issue 11 (3rd October 2022) Authors: Razi, Shazli; Bhardwaj, Vinay; Ouellette, Samantha; Khan, Samavia; Azadegan, Chloe; Boyd, Thomas; Rao, Babar Journal: Dermatologic therapy Issue: Volume 35:Issue 11(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Oral Azacitidine (CC-486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia. (13th October 2015) Authors: Cogle, Christopher R.; Scott, Bart L.; Boyd, Thomas; Garcia-Manero, Guillermo Journal: Oncologist Issue: Volume 20:Number 12(2015) Page Start: 1404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oral Azacitidine (CC‐486) for the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia. (13th October 2015) Authors: Cogle, Christopher R.; Scott, Bart L.; Boyd, Thomas; Garcia‐Manero, Guillermo Journal: Oncologist Issue: Volume 20:Number 12(2015) Page Start: 1404 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The potential prebiotic effect of 2‐Butyloctanol on the human axillary microbiome. (6th October 2021) Authors: Li, Min; Truong, Katie; Pillai, Shyamala; Boyd, Thomas; Fan, Aixing Journal: International journal of cosmetic science Issue: Volume 43:Number 6(2021) Page Start: 627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Treatment of CD30‐Expressing Germ Cell Tumors and Sex Cord Stromal Tumors with Brentuximab Vedotin: Identification and Report of Seven Cases. (8th December 2017) Authors: Albany, Costantine; Einhorn, Lawrence; Garbo, Lawrence; Boyd, Thomas; Josephson, Neil; Feldman, Darren R. Journal: Oncologist Issue: Volume 23:Number 3(2018) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗